Clopidogrel bisulfate is suitable for patients with recent stroke, myocardial infarction and confirmed peripheral artery disease. It can reduce the incidence of arteriosclerosis events (such as myocardial infarction, stroke and vascular death). Combined with aspirin for patients with non ST segment elevation acute coronary syndrome (unstable angina pectoris or non-Q-wave myocardial infarction).